13F-HR filed by REGENERON PHARMACEUTICALS, INC.
REGENERON PHARMACEUTICALS, INC. filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-01, with 4 holding rows worth $1,485,002,709.
- Accession
- 0001104659-25-073115
- Filer
- CIK 872589
- Filed
- 2025-08-01
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 4 entries on the cover page, a total value of $1,485,002,709 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,485,002,709 with VALUE read as dollars as filed, 13F file number 028-24826. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 4,444,445 | $1,449,289,070 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 3,702,995 | $34,734,093 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 968,183 | $590,592 | dollars as filed | |
| ADVERUM BIOTECHNOLOGIES INC | 00773U207 | COM NEW | 180,909 | $388,954 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-25-073115 | this filing | 2025-08-01 | acceptance time not in the bulk data set |